Comparison of Recurrence-Free Survival Between Hemihepatectomy and Non-hemihepatectomy in Patients with Hepatocellular Carcinoma ≥5 cm: A retrospective study (Orginal article)
Background As a standard anatomical liver resection procedure, hemihepatectomy offers the advantages of anatomical resection but also carries the disadvantage of removing more liver parenchyma. This retrospective study primarily evaluates the effect of hemihepatectomy on postoperative recurrence-free survival (RFS) in patients with large hepatocellular carcinoma exceeding 5 cm in diameter. Methods Data from dual-centers on HCC patients with solitary HCC ≥5 cm who underwent hepatectomy between January 2019 and December 2022 was analyzed retrospectively. Patients were categorized into hemihepatectomy and non-hemihepatectomy group based on the surgical approach. The primary endpoint was RFS. Propensity score matching (PSM) was employed to control for potential confounding variables between the two groups. Results A total of 266 enrolled patients were categorized into hemihepatectomy (n=86) and non-hemihepatectomy group (n=180). No significant difference in RFS was observed between these two groups either before (median 17.1 vs. 18.1 months, P = 0.984) or after PSM (median 20.6 vs. 18.1 months, P = 0.914). Cox regression identified AFP ≥200 ng/mL (HR = 1.866, 95% CI: 1.390-2.505,P < 0.001) and MVI positivity (HR = 1.882, 95% CI: 1.362-2.600,P < 0.001) as independent risk factors for reduced RFS. Conclusions In HCC tumors ≥5 cm, hemihepatectomy showed no significant RFS improvement compared to non-hemihepatectomy overall. Tumor biological characteristics (AFP levels and MVI status) are the primary determinants of postoperative prognosis in HCC patients.
Authors
- Jingfei Li (ORCID: https://orcid.org/0000-0002-4015-0690)
- D. C. Zhang
- Minzi Huan
- Kunyuan Jiang
- Jun Chang
Institutions
- University of Science and Technology of China (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-9651292/v1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- preprint